Lexeo Therapeutics Statistics
NASDAQ: LXEOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.96+0.01 (+0.34%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Lexeo Therapeutics by the numbers
Lexeo Therapeutics has a market capitalization of $245.1 million based on 82.79M shares outstanding. With trailing EPS of $-1.13, Lexeo Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.2% below its 50-day average and 39.3% below its 200-day average.
Average daily trading volume is 1.98M shares, or about $5.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LXEO valuation vs. peer median
| Metric | LXEO | Peer median | Difference |
|---|---|---|---|
| Market cap | $245.05M | $253.13M | -3% |
| Avg. volume | 1.98M | 768.54K | +157% |
Peer median across 8 companies: PLX, AUTL, EDIT, SABS, EIKN, SCTX, OCGN, AGMB.
Valuation
- Market cap
- $245.05M
- EPS (TTM)
- $-1.13
- Shares outstanding
- 82.79M
Price and trading
- Previous close
- 2.95
- Open
- 2.93
- Day range
- 2.89 – 3.25
- 52-week range
- 2.55 – 10.99
- 52-week change
- -67.33%
- Beta
- —
- Volume
- 1.80M
- Average volume
- 1.98M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 245.05M
- Forward Pe
- -2.00
- Eps
- -1.13
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.99
- Week52 Low
- 2.55
- Avg Volume
- 1.98M
- Shares Outstanding
- 82.79M
- Ma50
- 3.22
- Ma200
- 4.88
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -73.07%
- Pct From52w Low
- 16.08%